Title: Adherence to infliximab treatment in patients with immune-mediated inflammatory
diseases from a Referral Center in Brazil: A cohort study
Version: 2 Date: 27 Jul 2024
Reviewer's report:
This is a very well written research. the objectives were clear and the data analysis was objective.
The results of the study reflect the burden of inflammatory bowel disease on the lives of patients
with it.
Retrospective data collected from medical records are a weak point of the study, as they may
contain inaccuracies or be incomplete; in addition to the reference center bias that tends to
produce better results when compared to other real-life studies.
Title: Adherence to infliximab treatment in patients with immune-mediated inflammatory
diseases from a Referral Center in Brazil: A cohort study
Version: 2 Date: 27 Jul 2024
Reviewer's report:
This is a very well written research. the objectives were clear and the data analysis was objective.
The results of the study reflect the burden of inflammatory bowel disease on the lives of patients
with it.
Retrospective data collected from medical records are a weak point of the study, as they may
contain inaccuracies or be incomplete; in addition to the reference center bias that tends to
produce better results when compared to other real-life studies.
Please review this paper.
user
Title: Adherence to infliximab treatment in patients with immune-mediated inflammatory
diseases from a Referral Center in Brazil: A cohort study
Version: 2 Date: 27 Jul 2024
Reviewer's report:
This is a very well written research. the objectives were clear and the data analysis was objective.
The results of the study reflect the burden of inflammatory bowel disease on the lives of patients
with it.
Retrospective data collected from medical records are a weak point of the study, as they may
contain inaccuracies or be incomplete; in addition to the reference center bias that tends to
produce better results when compared to other real-life studies.
assistant